Inhibitory Effects of Cyclooxygenase-2 Inhibitory Drugs on Human Osteosarcoma and Lung Cancer Cell Lines
Fang-Zhou Chen
Abstract
Fang-Zhou Chen
Abstract
Objective To compare the effects of two cyclooxygenase-2 inhibitors,celecoxib and rofecoxib on the growth of human osteosarcoma (HOS-8603) and lung cancer cell (A-549) lines. Methods The anti-proliferation effects were determined by methabenzthiazuron (MTT) method. The cell growing cycle and the cell apoptosis were analyzed by flow cytometry. Results Cyclooxygenase-2 inhibitors, celecoxib and rofecoxib had inhibitory and apoptosis-inducting effect on the growth of the two tumor cell lines. The inhibitions of celecoxib and rofecoxib to the two tumor cell lines were dose-dependent and time-dependent. The cells treated with the two drugs showed a G_2/M arrest which was the peak time of apoptosis. There was a significant difference between rofecoxib and celecoxib groups ( P 0.05). And celecoxib had a stronger inhibition to HOS-8603 than rofecoxib. Conclusion Cyclooxygenase-2 inhibitors, celecoxib and rofecoxib have significant effect on the growth of the two tumor cell lines, and may become useful medicines in tumor treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the effects of two cyclooxygenase-2 inhibitors,celecoxib and rofecoxib on the growth of human osteosarcoma (HOS-8603) and lung cancer cell (A-549) lines. Methods The anti-proliferation effects were determined by methabenzthiazuron (MTT) method. The cell growing cycle and the cell apoptosis were analyzed by flow cytometry. Results Cyclooxygenase-2 inhibitors, celecoxib and rofecoxib had inhibitory and apoptosis-inducting effect on the growth of the two tumor cell lines. The inhibitions of celecoxib and rofecoxib to the two tumor cell lines were dose-dependent and time-dependent. The cells treated with the two drugs showed a G_2/M arrest which was the peak time of apoptosis. There was a significant difference between rofecoxib and celecoxib groups ( P 0.05). And celecoxib had a stronger inhibition to HOS-8603 than rofecoxib. Conclusion Cyclooxygenase-2 inhibitors, celecoxib and rofecoxib have significant effect on the growth of the two tumor cell lines, and may become useful medicines in tumor treatment.
Key concepts: Rofecoxib, Celecoxib, Cyclooxygenase, Apoptosis, Pharmacology, Cell growth, Medicine, Cell culture